VX-661 (Synonyms: Tezacaftor) |
Katalog-Nr.GC14920 |
VX-661 (VX-661) ist ein zweiter F508del-CFTR-Korrektor und hilft dem CFTR-Protein, die ZelloberflÄche zu erreichen.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1152311-62-0
Sample solution is provided at 25 µL, 10mM.
VX-661, one of vertex derivatives, corrects F508del-CFTR trafficking and increases F508del-CFTR protein activity in vitro [1].
VX-661 treated alone or in combination with ivacaftor have shown to enhance F508del-CFTR trafficking to the cell surface. VX-661 has been at phase 2 study [1].
References:
[1] S. Donaldson, J. Pilewski, M. Griese, Q. Dong, P.-S. Lee, for the VX11–661-101 Study Group. WS7.3 VX-661, an investigational CFTR corrector, in combination with ivacaftor, a CFTR potentiator, in patients with CF and homozygous for the F508Del-CFTR mutation: Interim analysis. Journal of Cystic Fibrosis, Volume 12, Supplement 1, June 2013, Page S14
Average Rating: 5
(Based on Reviews and 38 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *